At a glance
ClinicalIndex Comparison RecordN/ACompleted· 167 enrolled
Drug / intervention
Reliance 4-Front lead implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RELIANCE 4-FRONT™ Active Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study
In Brief
A clinical study evaluating Reliance 4-Front lead implantation for Tachycardia. Completed, enrolled 167 participants across 15 sites in 11 countries.
Detailed Summary
The objective of this study is to gather data to establish the chronic safety, performance and effectiveness of the RELIANCE 4-FRONT™ Active Fixation Defibrillation Leads.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTachycardia
CountriesAustria, China, Denmark, France, Germany, Israel, Italy, Portugal, Spain, Sweden, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
First PostedJan 2013
Primary CompletionJun 2014
Study CompletionAug 2016
TodayJul 2026
First PostedJan 21, 2013
Enrollment StartOct 1, 2012
Primary CompletionJun 1, 2014
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 13.4 years ago
Interventions
Reliance 4-Front lead implantationdevice
The patients selected for participation should be from the investigator's general patient population with an indication for implantation of a single or dual chamber ICD or CRT-D system.